Literature DB >> 6314206

Presynaptic alpha 2- and dopamine-receptor-mediated inhibitory mechanisms and dopamine nerve terminals in the rat hypothalamus.

H Ueda, Y Goshima, Y Misu.   

Abstract

Slices of rat hypothalamus were superfused and endogenous release of dopamine was measured. The potassium (20 mM)-evoked release in the presence of tetrodotoxin was Ca2+-dependent. The evoked release was reduced by adrenaline 10(-7) M, with a potent alpha 2-agonist action, and was reduced by a dopamine receptor agonist, apomorphine 10(-7) M, in the presence of yohimbine 10(-6) M. These inhibitory effects were antagonized by an alpha 2-antagonist, yohimbine 10(-6) M, and a dopamine receptor antagonist, (-)-sulpiride 10(-7) M, respectively. The electrically evoked release of DA was enhanced by (-)-sulpiride but not by the (+)-isomer. Taking into consideration that yohimbine at a relatively high concentration (10(-6) M) increases the electrically evoked DA release, it is suggested that DA release in the rat hypothalamus may be mediated not only via autoreceptors but also in part via presynaptic alpha 2-receptors on the DA nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6314206     DOI: 10.1016/0304-3940(83)90295-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices.

Authors:  Y Goshima; T Kubo; Y Misu
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

2.  Neurochemical correlates of behavioural responses to frustrative nonreward in the rat: implications for the role of central noradrenergic neurones in behavioural adaptation to stress.

Authors:  S C Stanford; P Salmon
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

3.  Dopamine binds to alpha(2)-adrenergic receptors in the song control system of zebra finches (Taeniopygia guttata).

Authors:  Charlotte A Cornil; Christina B Castelino; Gregory F Ball
Journal:  J Chem Neuroanat       Date:  2007-11-04       Impact factor: 3.052

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.